Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent

被引:249
作者
Khateri, S
Ghanei, M
Keshavarz, S
Soroush, M
Haines, D
机构
[1] JMERC, Chem Warfare Victims Res Unit, Org Vet Affairs, Janbazan Org,Hlth & Treatment Dept, Tehran, Iran
[2] Baghiatollah Hosp, Tehran, Iran
[3] Baghiatollah Univ Med Sci, Tehran, Iran
[4] George Washington Univ, Dept Epidemiol & Biostat, Washington, DC USA
关键词
D O I
10.1097/01.jom.0000094993.20914.d1
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Approximately 34,000 Iranians known to have sustained mustard agent exposure during the Iran-Iraq war of 1980-1988 and survived over a decade afterwards were screened for distribution of the most commonly occurring medical problems. In order of greatest incidence, these include lesions of the lungs (42.5%), eyes (39.3%), and skin (24.5%). Within each subpopulation, patients were ranked according to severity of lesions. Twenty-three percent to 37% of patients exhibited at least mild coverage, with 1.5% to 4.5% classed as moderate, and a much smaller population (0.023-1.0%) of the 34,000 patients exhibiting extensive (severe) lesional coverage. These results provide a comprehensive overview of the medical problem most common among mustard victims and could serve as a predictor of the likely impact of these weapons on health status of populations exposed to them during ongoing military conflicts.
引用
收藏
页码:1136 / 1143
页数:8
相关论文
共 56 条
[1]   Adversarial legalism and transaction costs: The industrial-flight hypothesis revisited [J].
Anderson, CL ;
Kagan, RA .
INTERNATIONAL REVIEW OF LAW AND ECONOMICS, 2000, 20 (01) :1-19
[2]   Protection of human upper respiratory tract cell lines against sulphur mustard toxicity by hexamethylenetetramine (HMT) [J].
Andrew, DJ ;
Lindsay, CD .
HUMAN & EXPERIMENTAL TOXICOLOGY, 1998, 17 (07) :373-379
[3]  
[Anonymous], 1986, TERRORISM ANAL DETEC
[4]  
Arroyo CM, 2000, J APPL TOXICOL, V21, pS63
[5]  
Asboe S, 1978, Ugeskr Laeger, V140, P2048
[6]  
ASLANI J, 1998, MIL MED, V1, P49
[7]  
Assennato G, 1997, Med Lav, V88, P148
[8]  
Azizi F, 1995, Med War, V11, P34, DOI 10.1080/07488009508409195
[9]  
Bagheri MH, 2003, ACTA RADIOL, V44, P241, DOI 10.1034/j.1600-0455.2003.00073.x
[10]  
Balali M., 1984, ARCH BELG S, P254